Can Oral Minoxidil Be the Game Changer in Androgenetic Alopecia? A Comprehensive Review and Meta-Analysis Comparing Topical and Oral Minoxidil for Treating Androgenetic Alopecia

Switching from topical to oral minoxidil may cause initial hair shedding, but oral minoxidil is likely more effective. Shedding should be temporary, and results should be monitored over a few months.

A 23-year-old male experiencing extreme hair shedding after increasing oral minoxidil to 2.5mg, previously used finasteride and dutasteride with minoxidil. Shedding is likely a common "minoxidil shed," indicating potential new hair growth.

The user experienced side effects from oral minoxidil, such as palpitations and insomnia, and switched to topical minoxidil, which led to noticeable hair regrowth, especially at the hairline. They also use finasteride and observed increased hair shedding initially, which later stabilized.

The user experienced significant hair shedding and dryness after starting minoxidil 8 months post-hair transplant, despite using finasteride and oils like castor and pumpkin seed oil. They expressed concern over the loss of density and the appearance of a failed transplant.

The user is using oral dutasteride, oral minoxidil, topical minoxidil, finasteride solution, tazarotene, calcipotriol, and a peptide serum for hair loss but is concerned about continued hair shedding. They are advised to stop smoking as it may worsen hair loss and to give the treatments more time to work.

Switching from topical to oral minoxidil caused prolonged hair shedding without regrowth, leading to the use of both topical and oral minoxidil with oral finasteride. Responses to these treatments vary, emphasizing the need for personalized approaches.